US Equity
TVRD
— TVARDI THERAPEUTICS, INC.Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing oral STAT3 inhibitors for cancer and inflammatory diseases.
💰 Market cap: $31.73M📍 3 Sugar Creek Ctr Blvd, Ste 525, SUGAR LAND, TX, 77478 US🏷️ Biotechnology & Medical Research💵 Previous close: $2.51🔢 9,878 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $2.51 |
| 2026-07-23 | $2.56 |
| 2026-07-22 | $2.76 |
| 2026-07-21 | $2.86 |
| 2026-07-20 | $2.93 |
| 2026-07-17 | $3.20 |
| 2026-07-16 | $3.08 |
| 2026-07-15 | $2.93 |
| 2026-07-14 | $3.10 |
| 2026-07-13 | $3.31 |
| 2026-07-10 | $3.28 |
| 2026-07-09 | $3.80 |
| 2026-07-08 | $5.00 |
| 2026-07-07 | $3.10 |
| 2026-07-06 | $2.01 |
| 2026-07-02 | $2.02 |
| 2026-07-01 | $1.95 |
| 2026-06-30 | $1.90 |
| 2026-06-29 | $1.91 |
| 2026-06-26 | $1.50 |
| 2026-06-25 | $2.36 |
| 2026-06-24 | $2.35 |
| 2026-06-23 | $2.42 |
| 2026-06-22 | $2.68 |
| 2026-06-18 | $2.63 |
| 2026-06-17 | $2.58 |
| 2026-06-16 | $2.63 |
| 2026-06-15 | $2.67 |
| 2026-06-12 | $2.64 |
| 2026-06-11 | $2.71 |
| 2026-06-10 | $2.70 |
| 2026-06-09 | $2.78 |
| 2026-06-08 | $2.85 |
| 2026-06-05 | $2.89 |
| 2026-06-04 | $3.08 |
| 2026-06-03 | $2.95 |
| 2026-06-02 | $3.17 |
| 2026-06-01 | $3.22 |
| 2026-05-29 | $3.38 |
| 2026-05-28 | $3.49 |
| 2026-05-27 | $3.30 |
| 2026-05-26 | $3.44 |
| 2026-05-22 | $3.57 |
| 2026-05-21 | $3.59 |
| 2026-05-20 | $3.85 |
| 2026-05-19 | $3.71 |
| 2026-05-18 | $4.00 |
| 2026-05-15 | $4.00 |
| 2026-05-14 | $3.96 |
| 2026-05-13 | $3.95 |
| 2026-05-12 | $3.98 |
| 2026-05-11 | $3.96 |
| 2026-05-08 | $4.18 |
| 2026-05-07 | $4.21 |
| 2026-05-06 | $3.66 |
| 2026-05-05 | $3.69 |
| 2026-05-04 | $3.54 |
| 2026-05-01 | $3.14 |
| 2026-04-30 | $3.15 |
| 2026-04-29 | $3.06 |
| 2026-04-28 | $3.20 |